Silent information regulator 1 protects the liver against ischemia-reperfusion injury: Implications in steatotic liver ischemic preconditioning

Transplant International

Volumn 27, Issue 5, 2014, Pages 493-503

  Pantazi, Eirini ^a,b   Zaouali, Mohamed Amine ^a,b,c   Bejaoui, Mohamed ^a,b   Serafin, Anna ^d   Folch Puy, Emma ^a,b   Petegnief, Valerie ^a   De Vera, Nuria ^a   Abdennebi, Hassen Ben ^c   Rimola, Antoni ^b,e   Rosellõ Catafau, Joan ^a,b  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF MONASTIR   (Tunisia)

^d Platform of Laboratory Animal Applied Research   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

ischemic preconditioning; liver ischemia reperfusion injury; nitric oxide; oxidative stress; Sirtuin 1

Indexed keywords

ADENOSINE PHOSPHATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 70; MITOGEN ACTIVATED PROTEIN KINASE; SIRTINOL; SIRTUIN 1; NOS3 PROTEIN, RAT; SIRT1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FATTY LIVER; ISCHEMIC PRECONDITIONING; LIPID PEROXIDATION ASSAY; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANIMAL; COMPLICATION; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION; ZUCKER RAT;

ANIMALS; APOPTOSIS; FATTY LIVER; HSP70 HEAT-SHOCK PROTEINS; ISCHEMIC PRECONDITIONING; LIVER; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; RATS; RATS, ZUCKER; REPERFUSION INJURY; SIRTUIN 1;

EID: 84898834107     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12276     Document Type: Article

References (59)

1. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transpl 2003; 9: 651.
2. Selzner M, Clavien PA,. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105.
3. Ramalho FS, Fernandez-Monteiro I, Rosello-Catafau J, Peralta C,. Hepatic microcirculatory failure. Acta Cir Bras 2006; 21 (Suppl. 1): 48.
4. Czubkowski P, Socha P, Pawlowska J,. Oxidative stress in liver transplant recipients. Ann Transplant 2011; 16: 99.
5. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C,. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002; 161: 587.
6. Massip-Salcedo M, Zaouali MA, Padrissa-Altes S, et al,. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology 2008; 47: 461.
7. Clavien PA, Selzner M, Rudiger HA, et al,. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843, discussion 51-2.
8. Brunet A, Sweeney LB, Sturgill JF, et al,. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011.
9. Peralta C, Bartrons R, Serafin A, et al,. Adenosine monophosphate- activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164.
10. Carrasco-Chaumel E, Rosello-Catafau J, Bartrons R, et al,. Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. J Hepatol 2005; 43: 997.
11. Finkel T, Deng CX, Mostoslavsky R,. Recent progress in the biology and physiology of sirtuins. Nature 2009; 460: 587.
12. Yeung F, Hoberg JE, Ramsey CS, et al,. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369.
13. Majmundar AJ, Wong WJ, Simon MC,. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010; 40: 294.
14. Pillarisetti S,. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent Pat Cardiovasc Drug Discov 2008; 3: 156.
15. Hernandez-Jimenez M, Hurtado O, Cuartero MI, et al,. Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 2013; 44: 2333.
16. Luo J, Nikolaev AY, Imai S, et al,. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107: 137.
17. Chen Z, Peng IC, Cui X, Li YS, Chien S, Shyy JY,. Shear stress, SIRT1, and vascular homeostasis. Proc Natl Acad Sci U S A 2010; 107: 10268.
18. Hou X, Xu S, Maitland-Toolan KA, et al,. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 2008; 283: 20015.
19. Lan F, Cacicedo JM, Ruderman N, Ido Y,. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008; 283: 27628.
20. Suchankova G, Nelson LE, Gerhart-Hines Z, et al,. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009; 378: 836.
21. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J,. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 2004; 95: 971.
22. Alcendor RR, Gao S, Zhai P, et al,. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 2007; 100: 1512.
23. Hsu CP, Zhai P, Yamamoto T, et al,. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010; 122: 2170.
24. Ruderman NB, Xu XJ, Nelson L, et al,. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010; 298: E751.
25. Serafin A, Rosello-Catafau J, Prats N, Gelpi E, Rodes J, Peralta C,. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004; 39: 688.
26. Liu FC, Day YJ, Liou JT, Lau YT, Yu HP,. Sirtinol attenuates hepatic injury and pro-inflammatory cytokine production following trauma-hemorrhage in male Sprague-Dawley rats. Acta Anaesthesiol Scand 2008; 52: 635.
27. Yan W, Fang Z, Yang Q, et al,. SirT1 mediates hyperbaric oxygen preconditioning-induced ischemic tolerance in rat brain. J Cereb Blood Flow Metab 2013; 33: 396.
28. Zaouali MA, Padrissa-Altes S, Ben Mosbah I, et al,. Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol 2010; 16: 5693.
29. Zaouali MA, Reiter RJ, Padrissa-Altes S, et al,. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury. J Pineal Res 2011; 50: 213.
30. Becatti M, Taddei N, Cecchi C, Nassi N, Nassi PA, Fiorillo C,. SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell Mol Life Sci 2012; 69: 2245.
31. Rane S, He M, Sayed D, et al,. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009; 104: 879.
32. Nadtochiy SM, Redman E, Rahman I, Brookes PS,. Lysine deacetylation in ischaemic preconditioning: the role of SIRT1. Cardiovasc Res 2010; 89: 643.
33. Raval AP, Dave KR, Perez-Pinzon MA,. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2006; 26: 1141.
34. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA,. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009; 159: 993.
35. Evankovich J, Cho SW, Zhang R, et al,. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem 2010; 285: 39888.
36. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y,. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007; 43: 571.
37. Mattagajasingh I, Kim CS, Naqvi A, et al,. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 2007; 104: 14855.
38. Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y,. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 2010; 17: 431.
39. Tajbakhsh N, Sokoya EM,. Regulation of cerebral vascular function by sirtuin 1. Microcirculation 2012; 19: 336.
40. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA, Seals DR,. SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 2011; 589: 4545.
41. Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, et al,. Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury. Crit Care Med 2008; 36: 1256.
42. Kume M, Yamamoto Y, Saad S, et al,. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 1996; 128: 251.
43. Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, et al,. Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol 2006; 168: 1474.
44. Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI,. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009; 323: 1063.
45. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y,. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 2002; 131: 344.
46. Kyriakis JM, Avruch J,. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807.
47. Nakano A, Baines CP, Kim SO, et al,. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res 2000; 86: 144.
48. Fryer RM, Patel HH, Hsu AK, Gross GJ,. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol 2001; 281: H1184.
49. Terada K, Kaziro Y, Satoh T,. Analysis of Ras-dependent signals that prevent caspase-3 activation and apoptosis induced by cytokine deprivation in hematopoietic cells. Biochem Biophys Res Commun 2000; 267: 449.
50. Datta G, Fuller BJ, Davidson BR,. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol 2013; 19: 1683.
51. Casillas-Ramirez A, Mosbah IB, Ramalho F, Rosello-Catafau J, Peralta C,. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 2006; 79: 1881.
52. Villalba JM, Alcain FJ,. Sirtuin activators and inhibitors. BioFactors 2012; 38: 349.
53. Schlicker C, Boanca G, Lakshminarasimhan M, Steegborn C,. Structure-based development of novel sirtuin inhibitors. Aging (Albany NY) 2011; 3: 852.
54. Narayan N, Lee IH, Borenstein R, et al,. The NAD-dependent deacetylase SIRT2 is required for programmed necrosis. Nature 2012; 492: 199.
55. Donmez G, Outeiro TF,. SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med 2013; 5: 344.
56. Yang SR, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I,. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292: L567.
57. Liu FC, Day YJ, Liao CH, Liou JT, Mao CC, Yu HP,. Hemeoxygenase-1 upregulation is critical for sirtinol-mediated attenuation of lung injury after trauma-hemorrhage in a rodent model. Anesth Analg 2009; 108: 1855.
58. Jung-Hynes B, Nihal M, Zhong W, Ahmad N,. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? J Biol Chem 2009; 284: 3823.
59. Wu SL, Yu L, Meng KW, Ma ZH, Pan CE,. Resveratrol prolongs allograft survival after liver transplantation in rats. World J Gastroenterol 2005; 11: 4745.